Integra LifeSciences Holdings Corporation Announces Introduction of Integra® Hollywood NanoMetalene Interbody Device
Published: Oct 09, 2013
PLAINSBORO, N.J., Oct. 9, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Integra® HollywoodTM NanoMetaleneTM Interbody Device (IBD), and expects to begin a controlled market release in the U.S. later this year. The IBD is used primarily in transforaminal lumbar interbody fusion (TLIF), a surgical procedure designed to help alleviate pain and nerve compression by fusing and stabilizing adjacent vertebrae in the lower back. Integra's newest IBD will be featured at the North American Spine Society (NASS) 28th annual meeting, October 9 – 12, 2013, in New Orleans, Louisiana.
Help employers find you! Check out all the jobs and post your resume.